Phosphoinositide 3-kinases (PI3Ks) are a family of enzymes extensively involved in cell signalling, acting downstream of tyrosine kinase and G-protein coupled receptors. Based on structural and substrate specificity, mammalian PI3Ks include class I (A, B), class II and class III enzymes. Several lines of evidence have shown that PI3Ks participate in the regulation of fundamental cellular functions such as cell growth, apoptosis, motility and vesicular trafficking, as well as in the modulation of physiological processes such as immunity, metabolism and cardiovascular physiology. Moreover, a deregulation of the PI3K pathway has been shown in several disease states such as cancer, inflammation and cardiovascular diseases, in human and animal models. Hence, the pharmacological inhibition of PI3Ks has emerged as a novel potential therapeutic option. Older and broad-spectrum PI3Ks inhibitors such as wortmannin and LY294002 have been useful tools for the elucidation of signaling pathways. However, isoform selectivity and adequate pharmacokinetic properties are now necessary for a selective therapeutic approach. Recently, the understanding of the crystallographic structure of PI3Ks has allowed the development of a multitude of inhibitors. In this review, we will present a general outline of PI3K functions in cellular, physiological and disease processes and discuss the main pharmacological compounds available for isoform-specific inhibition and the related evidence regarding their use in disease models.

Post-wortmannin era: Novel phosphoinositide 3-kinase inhibitors with potential therapeutic applications

Braccini, Laura;Morello, Fulvio;Perino, Alessia;Hirsch, Emilio
2009-01-01

Abstract

Phosphoinositide 3-kinases (PI3Ks) are a family of enzymes extensively involved in cell signalling, acting downstream of tyrosine kinase and G-protein coupled receptors. Based on structural and substrate specificity, mammalian PI3Ks include class I (A, B), class II and class III enzymes. Several lines of evidence have shown that PI3Ks participate in the regulation of fundamental cellular functions such as cell growth, apoptosis, motility and vesicular trafficking, as well as in the modulation of physiological processes such as immunity, metabolism and cardiovascular physiology. Moreover, a deregulation of the PI3K pathway has been shown in several disease states such as cancer, inflammation and cardiovascular diseases, in human and animal models. Hence, the pharmacological inhibition of PI3Ks has emerged as a novel potential therapeutic option. Older and broad-spectrum PI3Ks inhibitors such as wortmannin and LY294002 have been useful tools for the elucidation of signaling pathways. However, isoform selectivity and adequate pharmacokinetic properties are now necessary for a selective therapeutic approach. Recently, the understanding of the crystallographic structure of PI3Ks has allowed the development of a multitude of inhibitors. In this review, we will present a general outline of PI3K functions in cellular, physiological and disease processes and discuss the main pharmacological compounds available for isoform-specific inhibition and the related evidence regarding their use in disease models.
2009
5
2
66
86
http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/52301217.1/ben/cei/2009/00000005/00000002/art00001/F653A89598CBC47C1254409999CC0DD17C5367660C.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf
Cancer; Cardiovascular; Enzyme inhibitor; Inflammation; Phosphoinositide-3 kinase; Biochemistry; Molecular Medicine; Drug Discovery3003 Pharmaceutical Science
Braccini, Laura; Morello, Fulvio; Perino, Alessia; Hirsch, Emilio*
File in questo prodotto:
File Dimensione Formato  
Braccini_CEI-2009.pdf

Accesso riservato

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 838.17 kB
Formato Adobe PDF
838.17 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1668480
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 4
  • ???jsp.display-item.citation.isi??? ND
social impact